An observational study in Brain Injury, sponsored by Duke University. Completed at 1 site in United States. Open to participants aged 5 Days to 15 Years. Per ClinicalTrials.gov, last updated 2015-02-02.
Sponsored by Duke University · Observational
The purpose of this study is to assess for vasospasm using Transcranial Doppler (TCD) and brain injury biomarkers, and evaluate neurocognitive outcome data in pediatric traumatic brain injury (TBI) patients who have experienced a mild to severe head injury.
2,113 studies on the registry are indexed under Brain Injuries; 385 are open to participants now.
This study's enrollment of 6 is below the median of 100 across 690 observational studies indexed under Brain Injuries.
Browse Brain Injuries studies →Duke University is the lead sponsor of 2,025 studies on the registry; 275 are open to participants now.
Of its 194 completed or terminated interventional studies of FDA-regulated products, 159 (82%) have results posted.
Counted across the registry records on this site, refreshed daily.
Pediatric patients who have been admitted for a traumatic brain injury to Duke University Hospital.
Exclusion Criteria:
Children from 5 days to 15 years of age who have been admitted to the hospital with a traumatic brain injury.
Vasospasm detection by Transcranial Doppler Ultrasound
Daily transcranial doppler ultrasound performed in pediatric traumatic head injury patients.
Time frame: 8 days
Detection of biomarkers in pediatric traumatic brain injury
Detection of a defined set of protein biomarkers from biological samples collected upon enrollment, 12, 24, and 48 hours.
Time frame: 2 days
This study is completed, as verified in Jan 2015. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Duke University